Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects

Clinical trial NCT01631864 · COMPLETED

Trial details

NCT number: NCT01631864
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension Concurrent Obesity

Start date: 2012-10-01
Primary completion: 2013-07-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.